Systemic lupus erythematosus: a model for atherogenesis?

被引:62
作者
Manzi, S [1 ]
机构
[1] Univ Pittsburgh, Sch Med, Pittsburgh, PA 15213 USA
关键词
D O I
10.1093/rheumatology/39.4.353
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
[No abstract available]
引用
收藏
页码:353 / 359
页数:7
相关论文
共 84 条
[11]  
ESDAILE JM, 1998, ARTHRITIS RHEUM S9, V41, pA463
[12]   DYSLIPOPROTEINEMIA IN SYSTEMIC LUPUS-ERYTHEMATOSUS - EFFECT OF CORTICOSTEROIDS [J].
ETTINGER, WH ;
GOLDBERG, AP ;
APPLEBAUMBOWDEN, D ;
HAZZARD, WR .
AMERICAN JOURNAL OF MEDICINE, 1987, 83 (03) :503-508
[13]  
FEUSSNER G, 1993, HUM GENET, V92, P122
[14]  
Forte Trudy M., 1994, Current Opinion in Lipidology, V5, P354, DOI 10.1097/00041433-199410000-00007
[15]  
Gabriel S, 1998, ARTHRITIS RHEUM, V41, pS132
[16]   Vascular complications of diabetes mellitus: What role for phospholipid-binding antibodies? [J].
Galtier-Dereure, F ;
Biron, C ;
Vies, M ;
Bourgeois, V ;
Schved, JF ;
Bringer, J .
LUPUS, 1998, 7 (07) :469-474
[17]   Atherosclerosis-related markers in systemic lupus erythematosus patients: The role of humoral immunity in enhanced atherogenesis [J].
George, J ;
Harats, D ;
Gilburd, B ;
Levy, Y ;
Langevitz, P ;
Shoenfeld, Y .
LUPUS, 1999, 8 (03) :220-226
[18]   The syndrome of thrombosis, thrombocytopenia, and recurrent spontaneous abortions associated with antiphospholipid antibodies: Hughes syndrome [J].
Gharavi, AE ;
Wilson, WA .
LUPUS, 1996, 5 (05) :343-344
[19]   HOMOCYSTEINE-INDUCED MODULATION OF TISSUE-PLASMINOGEN ACTIVATOR BINDING TO ITS ENDOTHELIAL-CELL MEMBRANE-RECEPTOR [J].
HAJJAR, KA .
JOURNAL OF CLINICAL INVESTIGATION, 1993, 91 (06) :2873-2879
[20]   Involvement of beta(2)-glycoprotein I and anticardiolipin antibodies in oxidatively modified low-density lipoprotein uptake by macrophages [J].
Hasunuma, Y ;
Matsuura, E ;
Makita, Z ;
Katahira, T ;
Nishi, S ;
Koike, T .
CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 1997, 107 (03) :569-573